239 related articles for article (PubMed ID: 2533159)
21. Nilutamide: an antiandrogen for the treatment of prostate cancer.
Dole EJ; Holdsworth MT
Ann Pharmacother; 1997 Jan; 31(1):65-75. PubMed ID: 8997470
[TBL] [Abstract][Full Text] [Related]
22. Casodex: preclinical studies and controversies.
Furr BJ
Ann N Y Acad Sci; 1995 Jun; 761():79-96. PubMed ID: 7625752
[No Abstract] [Full Text] [Related]
23. Clinical progress with a new antiandrogen, Casodex (bicalutamide).
Blackledge GR
Eur Urol; 1996; 29 Suppl 2():96-104. PubMed ID: 8717470
[TBL] [Abstract][Full Text] [Related]
24. Casodex (bicalutamide): overview of a new antiandrogen developed for the treatment of prostate cancer.
Blackledge GR; Cockshott ID; Furr BJ
Eur Urol; 1997; 31 Suppl 2():30-9. PubMed ID: 9074908
[TBL] [Abstract][Full Text] [Related]
25. Update of monotherapy trials with the new anti-androgen, Casodex (ICI 176,334). International Casodex Investigators.
Iversen P
Eur Urol; 1994; 26 Suppl 1():5-9. PubMed ID: 7737258
[TBL] [Abstract][Full Text] [Related]
26. Are non-steroidal anti-androgens appropriate as monotherapy in advanced prostate cancer?
Boccon-Gibod L
Eur Urol; 1998; 33(2):159-64. PubMed ID: 9519357
[TBL] [Abstract][Full Text] [Related]
27. The kinetics of antiandrogens in humans.
Tremblay D; Dupront A; Meyer BH; Pottier J
Prog Clin Biol Res; 1987; 243A():341-50. PubMed ID: 2958859
[No Abstract] [Full Text] [Related]
28. French multicentre trial comparing Casodex (ICI 176,334) monotherapy with castration plus nilutamide in metastatic prostate cancer: a preliminary report.
Chatelain C; Rousseau V; Cosaert J
Eur Urol; 1994; 26 Suppl 1():10-4. PubMed ID: 7737255
[TBL] [Abstract][Full Text] [Related]
29. Relative potency of bicalutamide (Casodex) and flutamide (Eulexin).
Kolvenbag GJ; Furr BJ
Urology; 1999 Jul; 54(1):194-7. PubMed ID: 10414753
[No Abstract] [Full Text] [Related]
30. Endocrine profiles during administration of the new non-steroidal anti-androgen Casodex in prostate cancer.
Verhelst J; Denis L; Van Vliet P; Van Poppel H; Braeckman J; Van Cangh P; Mattelaer J; D'Hulster D; Mahler C
Clin Endocrinol (Oxf); 1994 Oct; 41(4):525-30. PubMed ID: 7525125
[TBL] [Abstract][Full Text] [Related]
31. Comparative effects of chronic administration of the non-steroidal antiandrogens flutamide and Casodex on the reproductive system of the adult male rat.
Chandolia RK; Weinbauer GF; Simoni M; Behre HM; Nieschlag E
Acta Endocrinol (Copenh); 1991 Nov; 125(5):547-55. PubMed ID: 1759544
[TBL] [Abstract][Full Text] [Related]
32. A randomised comparison of monotherapy with Casodex 50 mg daily and castration in the treatment of metastatic prostate carcinoma. Casodex Study Group.
Kaisary AV; Tyrrell CJ; Beacock C; Lunglmayr G; Debruyne F
Eur Urol; 1995; 28(3):215-22. PubMed ID: 8536775
[TBL] [Abstract][Full Text] [Related]
33. Effect of cyproterone acetate in comparison to flutamide on the ventral prostate of adult male castrated Copenhagen-Fisher rats and on Dunning R-3327 H tumors.
Donn F; Becker H; Klosterhalfen H; Klein H
Andrologia; 1989; 21(5):462-7. PubMed ID: 2530921
[TBL] [Abstract][Full Text] [Related]
34. Casodex (ICI 176,334), a new, non-steroidal anti-androgen. Early clinical results.
Lunglmayr G
Horm Res; 1989; 32 Suppl 1():77-81. PubMed ID: 2515147
[TBL] [Abstract][Full Text] [Related]
35. Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials. Prostate Cancer Trialists' Collaborative Group.
Lancet; 2000 Apr; 355(9214):1491-8. PubMed ID: 10801170
[TBL] [Abstract][Full Text] [Related]
36. The role of antiandrogen monotherapy in the treatment of prostate cancer.
Anderson J
BJU Int; 2003 Mar; 91(5):455-61. PubMed ID: 12603397
[TBL] [Abstract][Full Text] [Related]
37. ICI 176,334: a novel non-steroidal, peripherally selective antiandrogen.
Furr BJ; Valcaccia B; Curry B; Woodburn JR; Chesterson G; Tucker H
J Endocrinol; 1987 Jun; 113(3):R7-9. PubMed ID: 3625091
[TBL] [Abstract][Full Text] [Related]
38. [The use of Casodex (bicalutamide) in the treatment of disseminated prostatic cancer].
Sivko AV; Prokhorov AV
Urol Nefrol (Mosk); 1997; (3):49-52. PubMed ID: 9245060
[No Abstract] [Full Text] [Related]
39. Clinical applications of antiandrogens.
Namer M
J Steroid Biochem; 1988 Oct; 31(4B):719-29. PubMed ID: 2462132
[TBL] [Abstract][Full Text] [Related]
40. [Antiandrogen in prostate cancer].
Maeda O; Usami M
Nihon Rinsho; 2002 Dec; 60 Suppl 11():188-92. PubMed ID: 12599569
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]